Vidaza (Vidaza, Azacitidine) 100 mg for intravenous injection Celgene Switzerland
Article:
C-13
In Stock
Indications:
- Vidaza is used to treat adult patients who cannot be transplanted with hematopoietic stem cells and who have: - myelodysplastic syndrome (MDS) with a high or intermediate-2 degree of risk according to the IPSS (International Predictive Scoring System) scale; - acute myeloid leukemia; - chronic myelomonocytic leukemia without signs of MDS.125car/115pash
- Spelling errors: vedaz, vidaz, vidaz,
-
Commercial name:Vidaza
-
Сhemical name:Vidaza, azacitidine
-
Dosage:100 mg
-
Release form:Bottle
No reviews yet